Anixa Biosciences, Inc.
ANIX
4
|
$3.085
-2.68%
-2.76%
73K
|
Health Technology
(0.0% 1d) (-11.9% 1m) (-35.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-21.03% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 98,410,883
http://www.anixa.com
Sec Filling | Patents | 8 employees
(US) Anixa Biosciences, Inc. is a cancer-focused biotechnology company, which focuses on harnessing the body’s immune system in the fight against cancer. It operates through the following segments: Cancer Diagnostics, Cancer Therapeutics, and Legacy Patent Licensing Activities. Cancer Diagnostic segment develops CchekTM platform, a series of inexpensive non-invasive blood tests for the early detection of solid tumors, which is based on the body’s immune response to the presence of a malignancy. Cancer Therapeutics segment offers chimeric antigen receptor T-cell (CAR-T) based immuno-therapy drugs which genetically engineer a patient’s own immune cells to fight cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
cancer immunotherapy car-t t-cell genetic diagnostics ceiling
add to watch list Paper trade email alert is off
Press-releases
Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Published: 2024-03-14 (Crawled : 13:30) - biospace.com/
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: -0.94%
H: 1.9%
C: -2.22%
presentation meeting
Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: -1.23%
H: 2.18%
C: 0.62%
vaccine congress world presentation
Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
Published: 2024-02-12 (Crawled : 12:30) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 0.0%
H: 3.51%
C: -1.11%
cancer car-t trial
Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
Published: 2024-01-29 (Crawled : 15:00) - biospace.com/
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: -0.23%
H: 6.75%
C: 1.6%
conference
Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Published: 2024-01-23 (Crawled : 13:30) - biospace.com/
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 0.0%
H: 3.09%
C: 1.03%
patent vaccine cancer technology
Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
Published: 2024-01-10 (Crawled : 14:00) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: -0.25%
H: 11.85%
C: 9.38%
conference
Anixa Biosciences to Present at Biotech Showcase 2024
Published: 2023-12-14 (Crawled : 12:30) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 0.51%
H: 1.6%
C: -3.31%
biotech
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06 (Crawled : 23:00) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 2.29%
H: 5.63%
C: -10.45%
vaccine breast positive cancer study
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
Published: 2023-12-06 (Crawled : 21:00) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: 2.29%
H: 5.63%
C: -10.45%
conference vaccine breast positive cancer ongoing study
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
Published: 2023-11-27 (Crawled : 13:30) - prnewswire.com
ANIX 4 | $3.085 -2.68% -2.76% 73K
|
Health Technology
|
| O: -0.34%
H: 8.47%
C: 5.08%
patent vaccine cancer technology
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10